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Abstract Several small (\25aa) peptides have been
designedbasedonthesequenceofthedentinphosphoprotein,
one of the major noncollagenous proteins thought to be
involved in the mineralization of the dentin extracellular
matrix during tooth development. These peptides, consisting
of multiple repeats of the tripeptide aspartate-serine-serine
(DSS), bind with high afﬁnity to calcium phosphate com-
pounds and, when immobilized, can recruit calcium phos-
phate to peptide-derivatized polystyrene beads or to
demineralized human dentin surfaces. The afﬁnity of binding
to hydroxyapatite surfaces increases with the number of
(DSS)n repeats, and though similar repeated sequences—
(NTT)n,( D T T ) n,( E T T ) n,( N S S ) n,( E S S ) n,( D A A ) n,( A S S ) n,
and (NAA)n—also showed HA binding activity, it was gen-
erallynotatthesamelevelasthenaturalsequence.Bindingof
the(DSS)npeptidestosectionedhumanteethwasshowntobe
tissue-speciﬁc, with high levels of binding to the mantle
dentin,lowerlevelsofbindingtothecircumpulpaldentin,and
little or no binding to healthy enamel. Phosphorylation of the
serines of these peptides was found to affect the avidity, but
not the afﬁnity, of binding. The potential utility of these
peptides in the detection of carious lesions, the delivery of
therapeutic compounds to mineralized tissues, and the mod-
ulation of remineralization is discussed.
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The dentin phosphoprotein (DPP) is one of the major non-
collagenousproteinsfoundinthedentinextracellularmatrix
and has long been implicated in the nucleation of hydroxy-
apatite (HA) during dentin mineralization [1–4]. DPP is
found throughout the mineralized dentin in developing teeth
[5], and its transcript is expressed in odontoblasts concur-
rently with the initiationofdentinmineralization[1,6,7].In
addition,transientexpressionofthetranscriptencodingDPP
has been observed in ameloblasts [6, 7] as well as in
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beinvolvedinthemineralizationofalltoothlayersaswellas
the calciﬁcation of bone tissues.
In humans, DPP is the product of the dentin sialophos-
phoprotein (DSPP) gene, which encodes both DPP and the
dentin sialoprotein (DSP) as a single polypeptide, pre-
sumed to be proteolytically cleaved into DPP and DSP
immediately following translation [9]. While DSP has only
modest effects on HA formation, biochemical and genetic
studies have shown DPP to have profound effects on both
the rate of HA nucleation and the degree of order in the
resulting crystals [9, 10].
The ability of DPP to affect HA crystal growth and
nucleation in vitro has been studied extensively. In subcrit-
ical calcium phosphate solutions, immobilized DPP causes
marked increases in the rate of HA nucleation, though this
effect is not seen with DPP in free solution or with dephos-
phorylated DPP [11, 12]. In addition, high concentrations of
DPP inhibit HA crystal growth [4]. These activities have
been attributed to an aspartate- and serine-rich region within
the DPP sequence [2, 3, 13] consisting primarily of a large
number of repeats of the sequence Asp-Ser-Ser [9]. This
region is known to be highly ﬂexible [14] and highly phos-
phorylated [3] and is thought to nucleate HA crystal for-
mation by providing an optimal alignment of calcium ion
binding sites (or, at high enough concentrations, to cap the
surface of existing crystals to prevent further growth).
While some efforts have been made to explore the role of
this region in biomineralization, using synthetic peptides
consistingofalternatingaspartateandphosphoserineresidues
[3] or short highly phosphorylated peptides derived directly
fromtheDPPsequence[15],wechosetoexplorethenatureof
the fundamental repeat unit within DPP, Asp-Ser-Ser (DSS,
using the single-letter amino acid symbols), in the absence of
serinephosphorylation.Smallpeptideswithvaryingnumbers
of DSS repeats have been synthesized, and their roles in the
binding and deposition of calcium phosphate have been ana-
lyzed. Here, we present evidence that such peptides, ranging
inlengthfromsixto24aminoacids,comprisingrepeatsofthe
sequence(DSS)nandrelatedshortrepeats,canbindtocalcium
phosphates (HA and amorphous calcium phosphate) with
remarkablyhighafﬁnitiesandfurther,canbindtomineralized
tissues and recruit calcium phosphate to demineralized sur-
faces without phosphorylation.
Materials and Methods
Peptide Synthesis
The following peptide sequences were synthesized: 2DSS
(DSSDSS), 4DSS (DSSDSSDSSDSS), 6DSS (DSSDS
SDSSDSSDSSDSS), 8DSS (DSSDSSDSSDSSDSSDSSDS
SDSS), 4ESS (ESSESSESSESS), 4NSS (NSSNSSNSSN
SS), 4DTT (DTTDTTDTTDTT), 4ETT (ETTETTETT-
ETT), 4NTT (NTTNTTNTTNTT), 8DAA (DAADAADA-
ADAADAADAADAADAA), 8NAA (NAANAANAANAA
NAANAANAANAA), 8ASS (ASSASSASSASSASSAS-
SASSASS), #3-1 (LIKHILHRL).
Peptides were synthesized using standard Fmoc solid
phase chemistry on an Apex 396 multiple peptide synthe-
sizer (AAPPTec, Louisville, KY) at 0.015 mM scale.
Completed peptides were cleaved from the resin with 95%
triﬂuoroacetic acid and appropriate scavengers. Crude
peptide was puriﬁed to 90–95% purity using reverse-phase
high-performance liquid chromatography (ACTA Puriﬁer;
Amersham, Arlington Heights, IL), and peptide mass was
conﬁrmed by matrix-assisted laser desorption/ionization
(MALDI) mass spectroscopy. Peptides for use in binding
analyses were labeled with 5(6)-carboxyﬂuorescein prior to
cleavage, and peptides for use in assays requiring peptide
immobilization were C-terminally labeled with biotin
immediately following the cleavage step.
HA Binding Assay
Fluorescein-labeled DSS-containing peptides of various
lengths were subjected to pulldown assays as follows:
Samples containing varying concentrations of ﬂuorescein-
labeled peptide (0–100 lM) and a ﬁxed amount (0.3 mg)
of HA nanocrystals with a speciﬁc surface area of 100 m
2/g
(Berkeley Advanced Biomaterials, Berkeley, CA) were
prepared. Measurements were taken of the absorbance of
the labeled peptide at 488 nm (the peak absorbance of the
ﬂuorescein label) before and after exposure to the HA. The
amount of peptide bound was calculated by comparing the
ratio of the ﬁnal (Af) and initial (Ai) absorbances to the
initial concentration (C0)[ C bound = (Af/Ai)C0]. Plots were
generated of the amount of peptide bound per meter
squared of HA surface area vs. concentration of unbound
peptide at equilibrium. The resulting isotherms were ﬁt to
the Langmuir isotherm, x/m = (KANmaxCeq)/(1 ? KACeq),
where x/m represents the molar amount of peptide bound
per unit of HA surface area, KA is the afﬁnity constant of
the peptide for the HA surface (L/Mol), Nmax is the max-
imum surface concentration (mol/m
2), and Ceq is the molar
concentration of unbound peptide at equilibrium [16].
Binding of Calcium Phosphate to Immobilized DSS
Peptides
Streptavidin-coated polystyrene beads with an average
diameter of 4 lm (Spherotech, Lake Forest, IL) were
incubated with either biotin-conjugated 8DSS peptide or
unconjugated biotin (control beads). Beads were washed
with PBS to remove unbound peptide (or unbound biotin in
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CaCl2 ? 1 mM NaHPO4 for 12 days prior to imaging.
Mouse Bone Marrow Culture
Mouse bone marrow cultures were grown to conﬂuence in
DMEM ? 10% FBS and then treated continuously for
3 weeks with either 2.5 lM 5(6)-carboxyﬂuorescein-labeled
6DSSor2.5 lM5(6)-carboxyﬂuorescein-labeledpeptide#3-
1 (control peptide) in a-MEM ? 10% FBS ? 50 lg/mL
ascorbic acid ? 4m Mb-glycerophosphate. Cultures were
imaged by ﬂuorescence microscopy using a FITC excitation/
emission ﬁlter set.
Binding and Mineralization of Tooth Surfaces
Adult human molars, extracted during normal clinical
practice, were sagittally sectioned (Accutom-50, Copen-
hagen, Denmark; CA-231 diamond blade) and demineral-
ized with 19% ethylenediaminotetraacetic acid (EDTA) gel
for 1 h, followed by immersion in deionized water and
ultrasonication to remove debris. Samples were treated
with either 12.5 lM 8DSS peptide in 50 mM HEPES
buffer (pH 7.0) or buffer alone (no peptide) or were left
untreated for 1 h prior to remineralization with Quell
Desensitizer (Pentron Technologies, Wallingford, CT), a
remineralization solution consisting of aqueous solutions of
calcium chloride and potassium phosphate, for 15 min.
Samples were rinsed thoroughly prior to imaging by
scanning electron microscopy.
For binding experiments, sagittally sectioned adult
human molars were incubated for 10 min in a solution of
12.5 lM 5(6)-carboxyﬂuorescein-labeled 6DSS peptide
containing 10 mM NaCl and 50 mM HEPES, pH 7.0.
Control samples were prepared without peptide. Samples
were rinsed after treatment and imaged by confocal laser
scanning microscopy (CLSM) with illumination by a blue
Kr/Ar laser (k = 488 nm) and a FITC emission ﬁlter.
Results
Quantitative Analysis of DSS-Peptide Binding to HA
Surfaces
In order to quantitatively assess the strength of the DSS–
HA interaction as well as to determine the roles of peptide
length and sequence on binding, ﬂuorescein-labeled, DSS-
containing peptides of various lengths were subjected to
pulldown assays as described in ‘‘Materials and Methods.’’
The experimental data were ﬁt to the Langmuir isotherm,
which describes the binding of molecules to surfaces with
the conditions that (1) all binding sites have the same
afﬁnity for the peptide and (2) the peptide will form a
monolayer on the surface but cannot accumulate to higher
levels [17]. The excellent ﬁt of the Langmuir isotherm to
the experimental data validates these conditions, and the
constants obtained from this analysis were used for com-
parisons between peptides. As shown in Fig. 1a and sum-
marized in Table 1, both the binding afﬁnity (KA) and the
monolayer concentration (NMax) of the various peptides
increased with the number of DSS repeats per peptide.
Additionally, several variant peptides were tested (Fig. 1b,
c, Table 1): a peptide containing a longer side chain at the
ﬁrst position (4ESS), peptides containing a more sterically
hindered hydroxyl group at the second and third positions
(4DTT, 4NTT, 4ETT), peptides lacking a charged group at
the ﬁrst position (4NSS, 8ASS), and peptides lacking
hydroxyl groups at the second and third positions (DAA-8,
8NAA). By comparing the afﬁnities of these variants with
those of DSS-containing peptides of the same size, it was
determined that elimination of the negatively charged
residue (4NSS, 4NTT, Fig. 1b; 8ASS, Fig. 1c) resulted in
signiﬁcant loss of binding afﬁnity, while replacement of the
Ser residues with Thr or Ala (4DTT, 4ETT, Fig. 1b; DAA-
8, Fig. 1c) had little observable effect on this parameter
(e.g., DAA-8 has a KA that is within experimental error of
the KA for 8DSS). Peptides in which both the acidic residue
at the ﬁrst position and the serine residues at positions 2
and 3 were replaced (4NTT, Fig. 1b; 8NAA, Fig. 1c) led to
near-total loss of binding activity.
Because binding activity is determined by both the
binding afﬁnity (KA) and the maximum monolayer con-
centration (NMax), peptides that show similar afﬁnities can
vary widely in their overall activity due to differences in
NMax. Thus, while the presence of a negative charge at
position 1 of the repeat is clearly the key sequence
parameter in determining binding afﬁnity, these data sug-
gest that both the acidic residues and the serines are
involved in binding of these peptides to HA surfaces: Asp-
Ser-Ser is the optimal sequence giving rise to HA-binding
activity (due to the effect of the serines on the maximum
monolayer concentration), while all of the variant peptides
show markedly reduced binding to HA in vitro. Interest-
ingly, phosphorylation of the ﬁrst position of the DSS
repeat—peptide 4DS(P)S—did not lead to a signiﬁcant
change in binding afﬁnity relative to an unphosphorylated
peptide of the same size (peptide 4DSS) but rather gave a
large increase in the surface binding density, suggesting an
alteration in the binding mode rather than simply the
afﬁnity of the interaction (Table 1).
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Tissue Cultures
Having established that (DSS)n-containing peptides are able
to actively bind HA, we sought to determine whether they
would bind to emerging sites of mineralization in biologi-
cally derived tissue. Mouse bone marrow (MBM) cultures,
cultured under osteogenic conditions, were treated continu-
ously for 3 weeks with either labeled 6DSS peptide or
labeledpeptide#3–1(non-calcium-bindingcontrolpeptide).
Cultures were imaged by ﬂuorescence microscopy using a
FITC excitation/emission ﬁlter set. Figure 2b shows bright
staining of the mineralizing MBM nodules in the DSS-
treated sample, with no binding seen in the control sample
(Fig. 2d), indicating not only that the labeled 6DSS peptide
binds to mineralizing nodules in MBM cultures but also that
this binding is a property of the DSS sequence, rather than a
general property of small peptides.
Binding of Amorphous Calcium Phosphate
by DSS-Containing Peptides
To test the ability of DSS-containing peptides to recruit
calcium phosphate and to nucleate crystal growth, 25 lM
6DSS peptide was combined with varying concentrations
of CaCl2 and NaHPO4 and incubated as described in
‘‘Materials and Methods.’’ Though it was expected that
the presence of the free DSS-containing peptide
would enhance the formation of HA crystals at subcritical
Fig. 1 Equilibrium isotherms for binding of selected (DSS)n-con-
taining peptides and variants to HA. a Binding of (DSS)n-containing
peptides of various lengths. b, c binding of sequence variants
Table 1 Langmuir parameters of peptides described in this study,
based on ﬁts of the Langmuir equation to raw data
KA (M
-1) Nmax (mol/m
2) r
2DSS 57,000 ± 24,000 2.0 9 10
-8 ± 5 9 10
-9 0.94
4DSS 94,000 ± 26,000 5.8 9 10
-8 ± 6 9 10
-9 0.98
5DSS 148,000 ± 14,000 9.2 9 10
-8 ± 2 9 10
-9 0.99
6DSS 272,000 ± 26,000 1.3 9 10
-7 ± 3 9 10
-9 0.99
8DSS 290,000 ± 70,000 8.2 9 10
-8 ± 6 9 10
-9 0.99
4ESS 81,000 ± 18,000 4.6 9 10
-8 ± 4 9 10
-9 0.99
4NSS 16,000 ± 4,000 3.0 9 10
-8 ± 1 9 10
-8 0.99
4DTT 161,000 ± 79,000 1.3 9 10
-8 ± 1 9 10
-9 0.92
4ETT 79,000 ± 25,000 8.8 9 10
-8 ± 9 9 10
-9 0.94
4NTT 17,000 ± 7,000 5.8 9 10
-8 ± 2 9 10
-8 0.98
8DAA 310,000 ± 74,000 6.0 9 10
-8 ± 6 9 10
-9 0.99
8ASS ND ND ND
8NAA ND ND ND
4DS(P)S 83,000 ± 9,000 1.2 9 10
-7 ± 5 9 10
-9 0.99
ND not determined; binding parameters below detection limits for the
assay used
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123CaHPO4 concentrations, this was not observed (data not
shown). DSS-containing peptides containing C-terminal
biotin labels were then synthesized and immobilized on
streptavidin-coated beads. The beads were washed and
incubated in solutions containing varying concentrations of
CaHPO4 as before. Consistent with previous observations
for the dentin phosphoproteins/phosphophoryns as well as
other phosphoproteins [11, 12], these immobilized peptides
caused coaggregation of the beads with particles of amor-
phous CaHPO4 and eventually led to the deposition of
crystalline material around the bead. As illustrated in
Fig. 3a, nearly all peptide-coated beads were incorporated
into large aggregates of precipitated amorphous calcium
phosphate. By comparison, in the biotin-blocked control
sample, nearly all beads were unaggregated and unassoci-
ated with precipitate (Fig. 3b). Interestingly, several pep-
tide-coated beads became covered with more ordered
layers of mineral during the experiment (a representative is
shown in Fig. 3c), while all of the uncoated/biotin-blocked
control beads failed to accumulate mineral (Fig. 3d).
Tissue-Speciﬁc Binding of DSS Peptides to Tooth
Surfaces
To test binding of DSS-containing peptides to biological
tissue, sagittally sectioned human teeth were incubated
with 6DSS peptide (control samples were prepared without
peptide), washed, and imaged by CLSM. Figure 4 shows
the intense ﬂuorescent staining of the tooth by the labeled
peptide. Mock-treated control sections stained either with
scrambled peptide or with free 5(6)-carboxyﬂuorescein
showed no ﬂuorescence (not shown). Interestingly, this
peptide speciﬁcally binds to the dentin as no binding to the
enamel was seen (the leftmost edge of the stained area in
Fig. 4 corresponds to the dentin-enamel junction [DEJ]).
Examining the spatial pattern of dentin binding by labeled
6DSS (Fig. 4) reveals that staining is brightest in the
mantle dentin nearest the DEJ, with noticeably lower levels
of staining in the circumpulpal dentin, near the pulp cavity.
DSS-Mediated Remineralization of Tooth Surfaces
In Vitro
Having established that (DSS)n-containing peptides can
bind to the dentin surface and that immobilized peptides
could cause the accretion of calcium phosphate, we sought
to determine whether these peptides could be used to
recruit calcium phosphate to the dentin surface. Deminer-
alized sections of extracted human teeth were treated with
8DSS peptide and then subjected to remineralization with
Quell Desensitizer (Pentron Technologies), a commercially
available remineralization product consisting of aqueous
Fig. 2 Binding of ﬂuorescently labeled 6DSS peptide to mineralized
bone marrow nodules. MBM cultures were grown and imaged as
described in ‘‘Materials and Methods.’’ a Bright ﬁeld image of
mineralized mouse bone marrow nodules (MBMNs) from a culture
treated with 6DSS. b Fluorescence image of the ﬁeld shown in a. c
Bright ﬁeld image of mineralized MBMNs from a culture treated with
scrambled control peptide. d Fluorescence image of the ﬁeld shown in
c. Bars = 600 lm
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shown in the electron micrographs in Fig. 5, mock-treated
(Fig. 5c) and untreated samples (treated with desensitizer
only, Fig. 5d) showed low levels of mineral accumulation,
with several dentinal tubules remaining exposed. In con-
trast, DSS-treated dentin samples (Fig. 5b) accumulated a
continuous layer of calcium phosphate precipitate in the
presence of desensitizer solution, fully occluding the den-
tinal tubules.
Discussion
Biomineralization is one of the central processes in verte-
brate development and evolution [18] and references
within, affecting processes as diverse as feeding, locomo-
tion, predator avoidance, hearing, and balance. Defects in
mineralization or mineralized tissue proteins are involved
in human maladies ranging from hereditary deafness [19]
and atherosclerosis [20] to dental caries and osteoporosis.
Proteins that mediate the mineralization process offer us a
template for understanding how to manipulate the deposi-
tion of calcium compounds and thus potentially enhance
the treatment of calciﬁed tissue defects.
The ubiquitous presence of DPP at sites of calcium
phosphate deposition in mammals suggests that this protein
plays a direct role in the mineralization process [1, 5–8].
Biochemical studies have shown that DPP can indeed
affect the formation of biologically relevant HA crystals by
causing nucleation (at low concentrations) or inhibition (at
high concentrations) of crystal growth [4, 12]. Proteins
involved in mineralization processes in vertebrates
(including DPP) often contain negatively charged, Asp- or
Fig. 3 Interaction of immobilized 8DSS peptide with CaHPO4.
Streptavidin-coated polystyrene beads (4 lm average diameter) were
incubated with either biotin-conjugated 8DSS peptide (a, c)o r
unconjugated biotin (b, d). a Bright ﬁeld micrographs of amorphous
calcium phosphate aggregates accumulated around DSS-coated
beads. Bar = 4 lm. b Bright ﬁeld image of representative biotin-
blocked beads (no DSS peptide). Bar = 12 lm. c Phase-contrast
micrograph of a DSS-coated bead with a more ordered accretion of
calcium phosphate around its exterior. Bar = 4 lm. d Control sample
(biotin-blocked, no DSS peptide). Bar = 4 lm
Fig. 4 Binding of labeled DSS to dentin in human teeth. Top
Confocal image of ﬂuorescently labeled (DSS)8 peptide to a sectioned
human tooth, showing the enamel (E) and the dentin (D). Arrows
indicate the DEJ. Bottom Confocal image of the same tooth, in the
region between the mantle dentin (right) and the pulp cavity (left),
showing preference of this peptide for mantle dentin over circum-
pulpal dentin and enamel. Bars = 50 lm
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123Glu-rich domains ([21], and references within). This
observation combined with computational and biochemical
studies of the (DSS)n repeat region [2, 3, 13, 15] indicated
that this short repeated sequence governs the mineral
binding and nucleation activity of DPP.
Given the known dependence of DPP activity on its
phosphorylation state [11, 22], it was not surprising that
unphosphorylated DSS-containing peptides failed to
nucleate HA formation in free solution. However, we found
that even in the absence of phosphorylation, these peptides
bound tightly and speciﬁcally to calcium phosphate com-
pounds, suggesting that the (DSS)n motif itself may be
useful in identifying, illuminating, and manipulating cal-
ciﬁed surfaces.
In characterizing the behavior of these molecules, it was
found that the binding afﬁnities measured for the DSS pep-
tides compare favorably with afﬁnities measured for other
known HA-binding proteins and peptides. For example, the
HA binding afﬁnity of the 8DSS peptide (290,000 M
-1),
which consists of 24amino acids, is only sevenfoldless than
that of fully assembled amelogenin nanospheres
(1,970,000 M
-1)[ 23], which consist of up to 40 individual
*25-kDa subunits. Additionally, the C-terminal region of
amelogenin is reported to have an HA-binding afﬁnity of
6,200 M
-1 [24], while in contrast, the similarly sized 4DSS
peptidehasanafﬁnityof94,000 M
-1.Thebindingafﬁnityof
8DSS compares favorably with measured values for the
comparably sized histatins (K = 353,000–1,903,000 M
-1
[25]), a class of small antimicrobial peptides that are known
to bind HA with high afﬁnity.
Binding of DSS-containing peptides to deﬁned HA
substrates depends strongly on the length of the peptides,
with the afﬁnity increasing in proportion to peptide size up
to a length of six repeats (18 amino acids), with little
additional increase in afﬁnity seen in peptides with eight
repeats (Table 1). Six repeats thus appears to be optimal for
interaction with HA surfaces, possibly reﬂecting the max-
imum number of functional groups from the peptide that
can effectively interact with the surface at a given time. On
the other end of the length scale, the 2DSS peptide, con-
taining only two repeats of the DSS sequence, shows an
HA binding afﬁnity much lower than that of the longer
variants (57,000 M
-1) but well above values observed for
the binding of individual amino acids (5,000–13,200 M
-1
for phosphoserine [26, 27], 220 M
-1 for Asp [26],
206 M
-1 for glutamic acid [28]).
Peptide binding to HA surfaces also depended on their
sequence, with nearly all variant peptides showing signiﬁ-
cant reductions in binding afﬁnity relative to the parent DSS
sequence (Table 1, Fig. 1b, c). Our results show that the
primary sequence determinant of binding is a negative
charge at position 1 of the repeat. This is perhaps not sur-
prising,consideringthatstudiesofextremelylargepolymers
of aspartic acid show a very high HA binding afﬁnity
(3,000,000 M
-1fora28.8-kDapolymer[29]).Substitutions
of the serines in the DSS repeat also lead to reductions in
binding activity, albeit much less severely. In the past,
measurements of the binding afﬁnity of serine to HA have
ranged from those too low to subject to Langmuir analysis
[27] to much higher values (317,000 M
-1 but with a very
small numberof binding sites per meter squaredof HA [26])
depending on the speciﬁc HA preparation used, suggesting
the possibility of a complex and possibly highly speciﬁc
interaction between serine and discrete regions of HA sur-
faces. Our initial experiments indicate that binding of DSS-
containing peptides to HA results primarily from the con-
tributions of the aspartic acid residues, with the serines
playing a smaller but still signiﬁcant role.
Fig. 5 Scanning electron
micrographs of sagittal tooth
sections, treated as indicated: a
untreated control; b pretreated
with 8DSS for 1 h, rinsed, and
remineralized using Quell
desensitizer; c preincubated
with buffer (50 mM HEPES, pH
7.0), followed by
remineralization as in b; d no
preincubation, remineralization
as in b. Bars = 50 lm
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123Binding of (DSS)n-containing peptides to deﬁned HA
surfaces in vitro led us to investigate the binding of these
peptides to calciﬁed biological tissues. Fluorescein-labeled
8DSS peptide binds tightly to the dentin of extracted adult
human molars with remarkable tissue speciﬁcity, binding
primarily to the mantle dentin, with binding to the enamel
almost completely absent. It should be noted that the HA
crystalsofthedentinshowverydifferentmorphologiesfrom
those of the enamel, consisting of smaller, platelike crystals
with essentially random orientations, rather than the elon-
gated, well-oriented HA crystals of the enamel surface [10,
30].Thus,itispossiblethatthebindingspeciﬁcityof(DSS)n-
containing peptides to regions of the dentin may be due to
selective binding of this speciﬁc HA crystal form or (espe-
cially in light of the observed binding to amorphous calcium
phosphates)mayreﬂectasimplepreferenceofthesepeptides
for less ordered surfaces. Binding was also observed to
mineralizingmousebonemarrownodules,furtherindicating
that these peptides may be useful in identifying and manip-
ulating a wide variety of mineralized tissues.
Though the unphosphorylated DSS-containing peptides
examined in this study failed to nucleate HA formation in
free solution, they were able to effectively bind amorphous
calcium phosphate aggregates. By immobilizing these
peptides on a solid support, we were able to harness this
ability as a means of controlling the site of calcium phos-
phate deposition in saturated solutions. Polystyrene beads
with 8DSS peptide immobilized on their surfaces were
found to effectively aggregate amorphous calcium phos-
phate from saturated CaHPO4 solutions. Upon further
incubation, however, single beads were found to accrete
layers of more ordered, crystalline calcium phosphate, even
without phosphorylation of the peptides. This unexpected
behavior marks a departure from what has been observed
for the DPP protein and suggests that the full-length protein
likely contains additional regulatory mechanisms to help
govern HA nucleation. This result also suggests that the
(DSS)n-containing peptides can be enormously versatile in
manipulating the deposition of calcium phosphate.
Our investigations of the ability of (DSS)n-containing
peptides to initiate mineral deposition on tooth surfaces
revealed that pretreatment with 8DSS peptide markedly
enhanced the effectiveness of a commercially available
remineralization product in causing the aggregation of
mineral at the surface of partially demineralized dentin.
Molecular dynamics simulations using theoretical Asp/Ser
and Asp/phosphoserine-rich peptides have shown that these
peptides likely adopt extended conformations, presenting
functional groups on either side of a plane parallel to the
interactionsurface[13,31;D.K.Y.andW.S.,unpublished].
In the speciﬁc case of peptides based on the Asp-Ser-Ser
repeat,thishastheeffectofprovidingtwoequivalentmineral
binding faces, allowing surface-immobilized peptides to
actively bind passing amorphous calcium phosphate parti-
cles, thus leading to the observed increase in amorphous
calcium phosphate accumulation on 8DSS-pretreated HA
surfaces. This activity presents these peptides as promising
alternatives for enhancing tooth remineralization.
Theabilitytospeciﬁcally bindtocalciﬁedsurfacesandto
recruit calcium phosphate offers many other unique oppor-
tunities for diagnostic and therapeutic interventions. While
these activities resided in large proteins, it was not practical
to contemplate their use in clinical applications; but the
present demonstration of similar behavior by readily syn-
thesized small peptides provides the possibility of powerful
new tools to diagnose and treat disorders of calciﬁedtissues.
We have already presented the example of enhancing the
effectiveness of existing remineralization regimens by pre-
treatment of surfaces with (DSS)n-containing peptides, and
many other possibilities remain to be explored. Current
methods of diagnosing dental caries, e.g., rely on manual
probing, colorimetric staining, or laser-based ﬂuorimetry or
interferometrytoidentifythesitesofcariouslesions[32,33].
Given the afﬁnity of the (DSS)n peptides for amorphous
calcium phosphate and their lack of binding to healthy
enamel, ﬂuorescently labeled (DSS)n peptides could possi-
blybeusedtorapidlyidentifycariousandpre-cariouslesions
in teeth. This method would have far greater precision than
colorimetric dyes(reliance onwhich canlead totheremoval
of healthy enamel [34]) and improved sensitivity compared
to radiography or ﬂuorescence-based methods that rely on
native tissue ﬂuorescence.
Because (DSS)n-containing peptides can readily be
attached to any number of labels or accessory compounds,
their usefulness in diagnostic applications is limited only by
the range of their tissue speciﬁcity. We have made extensive
use of ﬂuorescently labeled peptides in this study, but it is
also possible to attach iodinated compounds for use as
radiographiccontrastagents[35]aswellasspin-labeledtags
to enhance contrast in magnetic resonance imaging. Yo-
kogawa et al. [36] showed that it was possible to target
estradiol to calciﬁed tissues by attaching it to short chains of
polyaspartate. Similarly, it is possible to attach therapeutic
compounds, such as antimicrobials or growth factors, to
(DSS)n-containing peptides in order to target their delivery
to speciﬁc calciﬁed surfaces with even greater precision.
Currently, efforts are under way to identify the range of
tissue speciﬁcity of these peptides and to engineer variants
with expanded or narrowed speciﬁcity that will allow us to
take advantage of their mineral binding activity in more
precise ways. The DPP is composed in large part of (DSS)n
repeats and exerts powerful effects on the rate and type of
mineralization in developing teeth [10]: By applying the
tools of peptide engineering to DPP-derived (DSS)n-like
peptides, we hope to unlock the full potential of this unique
mineral-binding motif.
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